In this opinion article, Maria Mantziri and Natália Hromníková argue how contrasting examples from pharmacovigilance’s past could point to a more proactive and vital future.

There was no chance the new head of the European Union’s medicines regulator could simply ease into the job. Emer Cooke, had Brexit and a pandemic on her desk from day one.

It's fifty years since Japan joined the WHO Programme for International Drug Monitoring (PIDM). Much has happened since then.